Sign in

CIK 0000875045

  • Large accelerated filer

BIOGEN INC.

Sign in to watch
Ticker
BIIB
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
330112644
Phone
+1 617-679-2000
Business address
225 BINNEY STREET, CAMBRIDGE, MA, 02142
Former names
BIOGEN IDEC INC., BIOGEN IDEC INC, IDEC PHARMACEUTICALS CORP / DE, IDEC PHARMACEUTICALS CORP / CA
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Planned sale Head of Development sold 634 shares at $245.93 ($155,920)
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 3 Insider Initial Statement of Ownership
  12. 4 Planned sale Head of Development sold 110 shares at $248.00 ($27,280)
  13. 4 Shares withheld for taxes Chief Accounting Officer gave up 170 shares (to pay taxes)
  14. 4 Derivatives Options or other derivatives
  15. 3 Insider Initial Statement of Ownership
  16. 4 Open-market sale 10% owner sold 6,000,000 shares at $0.50 ($3,000,000)
  17. 4 Shares withheld for taxes EVP, Chief Financial Officer gave up 2,704 shares (to pay taxes)
  18. 4 Planned sale Head of Development sold 431 shares at $269.43 ($116,124)
  19. 3 Insider Initial Statement of Ownership
  20. 4 Shares withheld for taxes Head of Global Product Strat. gave up 244 shares (to pay taxes)

Page 7 of 86 · 1,714 filings